INTENSIV TERAPIYADA VAZOPRESSORLAR QO‘LLANILGANDA QON TOMIRLARDAGI MORFOLOGIK O‘ZGARISHLAR
##semicolon##
vazopressorlar##common.commaListSeparator## noradrenalin##common.commaListSeparator## vazopressin##common.commaListSeparator## endotelial disfunktsiya##common.commaListSeparator## glikokaliksAbstrak
Vazopressorlar (noradrenalin, vazopressin, fenilefrin, adrenalin) sepsis, kardiogen va gipovolemik shokda hayotiy organlarning perfuziyasini ta'minlashda muhim usul bo'lib qolmoqda. Biroq, vazopressorlarning uzoq muddatli yoki yuqori dozalarda qo'llanilishi ko'pincha refrakter vazoplegiya, ishemik-reperfuzion organ zararlanishi va ko'p organ disfunktsiyasining rivojlanishi bilan bog'liq.
##submission.citations##
1. Annane D, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet. 2007;370(9588):676-684.
2. Asfar P, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583-1593.
3. Avontuur JA, et al. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study. Crit Care Med. 1998;26:660-667.
4. Baker T, et al. Endothelial injury in sepsis: from bench to bedside. Intensive Care Med. 2023;49:1035-1048.
5. Becker BF, et al. The endothelial glycocalyx in critical illness: a pediatric and adult considerations. Crit Care. 2024;28:112.
6. Brown RM, et al. Balanced crystalloids versus saline in sepsis (SMART trial). N Engl J Med. 2018;378:829-839.
7. Byrne L, et al. The glycocalyx is a key determinant of fluid responsiveness in septic shock. Crit Care Med. 2021;49:e115-e124.
8. De Backer D, et al. Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome. Crit Care Med. 2013;41:791-799.
9. Dünser MW, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107:2313-2319.
10. Evans L, et al. Surviving Sepsis Campaign: International Guidelines 2021. Intensive Care Med. 2021;47:1181-1247.
11. Gordon AC, et al. Levosimendan for the prevention of acute organ dysfunction in sepsis (LeoPARDS). N Engl J Med. 2016;375:1638-1648.
12. Hollenberg SM. Vasoactive drugs in circulatory shock. Am J Respir Crit Care Med. 2011;183:847-855.
13. Ince C, et al. The endothelium in sepsis. Shock. 2016;45:259-270.
14. Joffre J, et al. Endothelial glycocalyx damage in sepsis: from experimental models to clinical practice. Intensive Care Med Exp. 2022;10:44.
15. Khanna A, et al. Angiotensin II for the treatment of vasodilatory shock (ATHOS-3). N Engl J Med. 2017;377:419-430.
16. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 2001;345:588-595.
17. Laterre PF, et al. Selepressin in septic shock: a randomised, placebo-controlled phase 2b/3 trial (SEPSIS-ACT). Lancet Respir Med. 2021;9:264-275.
18. Levy B, et al. Vasopressin versus norepinephrine in septic shock: a propensity score matched analysis. Crit Care. 2018;22:174.
19. Martin C, et al. Damage to the endothelial glycocalyx is an early predictor of multiple organ failure after trauma. Ann Surg. 2023;277:e112-e120.
20. Milne B, et al. Norepinephrine induces apoptosis in endothelial cells via α2-adrenoceptor-mediated calcium signaling. Crit Care Med. 2022;50:e421-e431.
21. Myburgh JA, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care (CHEST). N Engl J Med. 2012;367:1901-1911.
22. Oberholzer A, et al. Catecholamines induce endothelial cell apoptosis via generation of reactive oxygen species. Shock. 2002;17:461-467.
23. Orbegozo D, et al. Effects of norepinephrine on microcirculatory perfusion and glycocalyx integrity. Crit Care. 2019;23:45.
24. Russell JA, et al. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery (VANCS). JAMA. 2017;317:934-943.
25. Schmidt EP, et al. The pulmonary endothelial glycocalyx in sepsis: mechanisms and therapeutic potential. Am J Physiol Lung Cell Mol Physiol. 2023;324:L1-L14.
26. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351:159-169.
27. Trzeciak S, et al. Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med. 2008;34:2210-2217.
28. Uchimido R, et al. Shedding of the endothelial glycocalyx during sepsis: mechanisms and clinical relevance. Front Immunol. 2019;10:1583.
29. Vincent JL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344-353.
30. Yaghi A, et al. Norepinephrine-induced pulmonary edema is associated with loss of endothelial glycocalyx. Am J Respir Crit Care Med. 2023;207:890-902.
